Insider · CIK 0001190558

SIEBERT JOHN M

Reports to the SEC for 3 companies · LENEXA, KS

sec.gov

Transactions

Companies

Filings

CIK

0001190558

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,886 sh	—	—	0
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+3,886 sh	—	—	87,943
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,369 sh	—	—	5,369
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+8,252 sh	—	—	8,252
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,886 sh	—	—	3,886
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+6,293 sh	—	—	6,293
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,882 sh	—	—	0
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+3,882 sh	—	—	84,057
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,882 sh	—	—	3,882
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+6,847 sh	—	—	6,847
2022-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+4,222 sh	—	—	80,175
2022-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,222 sh	—	—	0
2021-08-11	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$12.98	+$195K	75,953
2021-08-11	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2021-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,365 sh	—	—	7,365
2021-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,222 sh	—	—	4,222
2020-02-21	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+5,211 sh	$23.99	+$125K	60,953
2020-02-21	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+9,305 sh	—	—	9,305
2019-06-20	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2019-06-20	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$9.13	+$91.3K	55,742
2019-04-25	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$9.13	+$91.3K	45,742
2019-04-25	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	10,000
2019-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,427
2019-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,427
2018-08-20	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+8,722 sh	$7.90	+$68.9K	28,285
2018-08-20	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,457 sh	$9.24	+$68.9K	35,742
2018-08-20	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,722 sh	—	—	0
2018-08-20	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,457 sh	—	—	0
2018-03-22	ARADIGM CORPStock Option (Right to Buy)A Award	Director, Interim Principal Exec Ofcr	AAward	+276K sh	—	—	276,000
2018-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+8,613 sh	—	—	8,613
2017-06-13	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+6,036 sh	—	—	6,036
2017-06-01	ARADIGM CORPStock Option (Right to Buy)A Award	Director, Interim Principal Exec Ofcr	AAward	+110K sh	—	—	110,485
2017-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,905 sh	—	—	7,905
2016-06-09	ARADIGM CORPStock Option (Right to Buy)A Award	Director, Interim Principal Exec Ofcr	AAward	+35.9K sh	—	—	35,941
2016-03-01	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-11-12	ARADIGM CORPStock Option (Right to Buy)A Award	Director, Interim Principal Exec Ofcr	AAward	+19.9K sh	—	—	19,940
2015-03-03	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2014-12-16	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,188 sh	$4.24	+$9,277.12	19,563
2014-12-16	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,188 sh	—	—	2,187
2014-01-21	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,457 sh	—	—	7,457
2013-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,187 sh	$4.24	+$9,272.88	17,375
2013-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,187 sh	—	—	4,375
2013-05-22	ARADIGM CORPA Award	Director, Interim Principal Exec Ofcr	AAward	+100K sh	$0.15	+$15K	501,697
2013-05-22	ARADIGM CORPStock Option (Right to Buy)A Award	Director, Interim Principal Exec Ofcr	AAward	+140K sh	—	—	140,000
2013-03-21	SUPNSUPERNUS PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+3,000 sh	$5.50	+$16.5K	15,188
2013-02-05	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+8,722 sh	—	—	8,722
2012-12-14	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,188 sh	$4.24	+$9,277.12	12,188
2012-12-14	SUPNSUPERNUS PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,188 sh	—	—	6,562
2012-12-04	SUPNSUPERNUS PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+7,000 sh	$8.14	+$57K	10,000
2012-05-25	ARADIGM CORPA Award	Director, Interim Principal Exec Ofcr	AAward	+100K sh	—	—	401,697

Recent filings

Accepted (ET)
Feb 274
SIEBERT JOHN M0001104659-24-028277
SEC(opens sec.gov)
Feb 264
SIEBERT JOHN M0001104659-24-027576
SEC(opens sec.gov)
Feb 274
SIEBERT JOHN M0001104659-23-026073
SEC(opens sec.gov)
Feb 244
SIEBERT JOHN M0001104659-23-025383
SEC(opens sec.gov)
Feb 244
SIEBERT JOHN M0001104659-22-026880
SEC(opens sec.gov)
Feb 234
SIEBERT JOHN M0001104659-22-026096
SEC(opens sec.gov)
Aug 124
SIEBERT JOHN M0001104659-21-104206
SEC(opens sec.gov)
Feb 234
SIEBERT JOHN M0001104659-21-026930
SEC(opens sec.gov)
Feb 254
SIEBERT JOHN M0001104659-20-024846
SEC(opens sec.gov)
Jun 244
SIEBERT JOHN M0001104659-19-037264
SEC(opens sec.gov)

Companies

Address

C/O CYDEX, INC. 10513 W. 84TH TERRACE

LENEXA, KS, 66214